Literature DB >> 18539226

Trachoma.

Heathcote R Wright1, Angus Turner, Hugh R Taylor.   

Abstract

Trachoma is a keratoconjunctivitis caused by ocular infection with Chlamydia trachomatis. Repeated or persistent episodes lead to increasingly severe inflammation that can progress to scarring of the upper tarsal conjunctiva. Trichiasis develops when scarring distorts the upper eyelid sufficiently to cause one or more lashes to abrade the cornea, scarring it in turn and causing blindness. Active trachoma affects an estimated 84 million people; another 7.6 million have end-stage disease, of which about 1.3 million are blind. Trachoma should stand on the brink of extinction thanks to a 1998 initiative launched by WHO--the Global Elimination of Trachoma by 2020. This programme advocates control of trachoma at the community level with four inter-related population-health initiatives that form the SAFE strategy: surgery for trichiasis, antibiotics for active trachoma, facial cleanliness, and environmental improvement. Evidence supports the effectiveness of this approach, and if current world efforts continue, blinding trachoma will indeed be eliminated by 2020.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18539226     DOI: 10.1016/S0140-6736(08)60836-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  75 in total

1.  [Diagnosis and treatment of Chlamydia trachomatis infections].

Authors:  T Meyer
Journal:  Hautarzt       Date:  2012-01       Impact factor: 0.751

2.  Elimination of blinding trachoma in oman.

Authors:  Rajiv Khandekar
Journal:  Oman Med J       Date:  2009-04

3.  Short-sightedness in sight-saving: half a strategy will not eliminate blinding trachoma.

Authors:  Maggie A Montgomery; Jamie Bartram
Journal:  Bull World Health Organ       Date:  2010-02       Impact factor: 9.408

Review 4.  Bacterial nucleators: actin' on actin.

Authors:  Joana N Bugalhão; Luís Jaime Mota; Irina S Franco
Journal:  Pathog Dis       Date:  2015-09-27       Impact factor: 3.166

Review 5.  Control of neglected tropical diseases needs a long-term commitment.

Authors:  Yaobi Zhang; Chad MacArthur; Likezo Mubila; Shawn Baker
Journal:  BMC Med       Date:  2010-10-29       Impact factor: 8.775

6.  Childhood mortality in a cohort treated with mass azithromycin for trachoma.

Authors:  Jeremy D Keenan; Berhan Ayele; Teshome Gebre; Mulat Zerihun; Zhaoxia Zhou; Jenafir I House; Bruce D Gaynor; Travis C Porco; Paul M Emerson; Thomas M Lietman
Journal:  Clin Infect Dis       Date:  2011-04-01       Impact factor: 9.079

7.  Chlamydia trachomatis secretion of hypothetical protein CT622 into host cell cytoplasm via a secretion pathway that can be inhibited by the type III secretion system inhibitor compound 1.

Authors:  Siqi Gong; Lei Lei; Xiaotong Chang; Robert Belland; Guangming Zhong
Journal:  Microbiology (Reading)       Date:  2011-01-13       Impact factor: 2.777

8.  Comparing the effectiveness of shared versus private latrines in preventing trachoma in rural Tanzania.

Authors:  Maggie A Montgomery; Mayur M Desai; Menachem Elimelech
Journal:  Am J Trop Med Hyg       Date:  2010-04       Impact factor: 2.345

9.  Active trachoma among children in Mali: Clustering and environmental risk factors.

Authors:  Mathieu Hägi; Jean-François Schémann; Frédéric Mauny; Germain Momo; Doulaye Sacko; Lamine Traoré; Denis Malvy; Jean-François Viel
Journal:  PLoS Negl Trop Dis       Date:  2010-01-19

10.  Neglected tropical diseases in sub-saharan Africa: review of their prevalence, distribution, and disease burden.

Authors:  Peter J Hotez; Aruna Kamath
Journal:  PLoS Negl Trop Dis       Date:  2009-08-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.